Literature DB >> 30107473

Six-Month Comparative Analysis Monitoring the Progression of the Largest Diameter of the Sweating Inhibition Halo of Different Botulinum Toxins Type-A.

Adilson da Costa1, Elisangela Samartin Pegas Pereira2, Margareth de Oliveira Pereira2, Felipe Borba Calixto Dos Santos2, Raquel Fávaro2, Lissa Sabino de Matos2, Thaísa Saddi Tannous2, Carla Oliveira Parra Duarte3, Caroline Silva Pereira2.   

Abstract

BACKGROUND: Excessive sweating is a clinical condition that can be improved with type-A botulinum toxin (BTX-A).
OBJECTIVES: To evaluate and compare the largest diameter of sweating inhibition halo (SIH) of 5 different commercially available BTX-A, in five different doses, in a 6-month-long clinical evaluation.
METHODS: Twenty-five adult female volunteers were injected in the dorsal trunk area with both 100 units (100UI) and 500 units (500UI) BTX-A products, reconstituted in a ratio of 1:2.5 IU, respectively. Products were applied in five different concentrations (1:2.5U, 2:5U, 3:7.5U, 4:10U, and 5:12.5U). After 30, 60, 90, 120, 150, and 180 days, a starch-iodine test was performed to obtain the largest diameter of each SIH.
RESULTS: The higher the number of units used, the larger the SIH p < 0.05 for all BTX-A. However, Botox®, Botulift®, Dysport®, and Prosigne® have pretty likewise SIH along the study, with some few differences for some doses and months between one and another. However, Xeomin® is the BTX-A with the smallest SIH, in comparison with all others, in any dose and period.
CONCLUSIONS: Differences were observed among all brands of BTX-As, based on dose and time after injection. Xeomin® provides the smallest SIH in comparison with others BTX-A.
© 2018 The American Society for Aesthetic Plastic Surgery, Inc. Reprints and permission: journals.permissions@oup.com.

Entities:  

Year:  2019        PMID: 30107473     DOI: 10.1093/asj/sjy207

Source DB:  PubMed          Journal:  Aesthet Surg J        ISSN: 1090-820X            Impact factor:   4.283


  6 in total

Review 1.  [New botulinum toxins for aesthetic dermatology : A comprehensive review].

Authors:  A Patil; M Kassir; U Wollina; M Goldust
Journal:  Hautarzt       Date:  2021-04-06       Impact factor: 0.751

2.  Evaluating the Effect of Incobotulinumtoxin A for Glabellar, Forehead, and Crow's Feet Lines Using A High Dilution.

Authors:  Sheila C Barbarino; Jani A J van Loghem; Cheryl M Burgess; Niamh Corduff
Journal:  J Clin Aesthet Dermatol       Date:  2021-08-01

3.  Safety and efficacy of botulinum toxin type A in preventing and treating scars in animal models: A systematic review and meta-analysis.

Authors:  Lingfeng Pan; Haiyan Qin; Caihong Li; Liehao Yang; Mingxi Li; Jiao Kong; Guang Zhang; Lianbo Zhang
Journal:  Int Wound J       Date:  2021-08-17       Impact factor: 3.099

4.  One21: A Novel, Customizable Injection Protocol for Treatment of the Forehead with IncobotulinumtoxinA.

Authors:  Carla de Sanctis Pecora
Journal:  Clin Cosmet Investig Dermatol       Date:  2020-02-05

Review 5.  Botulinum Toxin Type A to Improve Facial Symmetry in Facial Palsy: A Practical Guideline and Clinical Experience.

Authors:  Carla de Sanctis Pecora; Danielle Shitara
Journal:  Toxins (Basel)       Date:  2021-02-18       Impact factor: 4.546

6.  OnabotulinumtoxinA Displays Greater Biological Activity Compared to IncobotulinumtoxinA, Demonstrating Non-Interchangeability in Both In Vitro and In Vivo Assays.

Authors:  David Rupp; Greg Nicholson; David Canty; Joanne Wang; Catherine Rhéaume; Linh Le; Lance E Steward; Mark Washburn; Birgitte P Jacky; Ron S Broide; Wolfgang G Philipp-Dormston; Mitchell F Brin; Amy Brideau-Andersen
Journal:  Toxins (Basel)       Date:  2020-06-13       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.